Novel Hep C Vaccine in Phase 1 Trial
New vaccine for hepatitis C underway
A new vaccine for hepatitis C had been developed by a team of experts recently. The first clinical trial for testing the efficacy of the vaccine has yielded positive results, as reported by Oxford University professionals.
The vaccine was developed by a collaboration of scientists from the Oxford University, the University of Birmingham and an Italian biotech company. This team aimed to use a new avenue to instigate a distinct arm of the immune mechanism than the one used in initial studies. This injection is formulated to enable T cell responsiveness to the more consistent areas of the hepatitis C virus, instead of striking the outer coat of the virus which keeps varying persistently.
Continue reading this entire article:
http://www.healthjockey.com/2012/01/05/new-vaccine-for-hepatitis-c-underway/#